Actively Recruiting
Using 3T Multiparametric MRI Radiomics to Predict Perilesional Infiltration in Bone Cancer and Soft Tissue Sarcoma Before Surgery
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-14
122
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting an observational study to explore how well radiomics can diagnose the infiltration of tumors near lesions in people suspected of having Bone Cancer Tumors or Soft Tissue Sarcoma STS. The study aims to find out if radiomics can accurately identify those truly diagnosed as positive among all positive test results and also determine the likelihood that a negative test result means the participant does not have the disease. Participants in this study will receive an MRI as part of their usual medical care. Their MRI data will be collected anonymously and analyzed to develop a radiomics model that might help predict tumor infiltration before surgery. There are no additional treatments or interventions beyond the standard MRI scan. During the study, which lasts up to two years from enrollment, researchers will evaluate the positive predictive value and negative predictive value of the radiomics approach. Participants medical information will be reviewed securely and anonymously, with no extra procedures required. The study is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna and started in March 2025, with completion expected by October 2028.
CONDITIONS
Brief Title
Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor
Research Team
V
Vincenzo Lucidi, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here